Implementation of the Track and Trace system for export of Pharmaceuticals and drug consignments along with maintaining the Parent-Child relationship in the levels of packaging and their movement in supply chain - Extension of date of implementation regarding
📋
Contents
Cases Cited
Referred In
Notifications
Circulars
Forms
Manuals
Acts
Rules & Regulations
Case Laws New
Ref Provisions New
Plus +
Source NTF
Summary
Similar
Note
Bookmark
Share
✓ Copied successfully !
Print
Print Options
For full text, please login
Login to TaxTMI
Verification Pending
The Email Id has not been verified. Click on the link we have sent on
Track and Trace system implementation extended for pharmaceutical exports; exporters must maintain parent child packaging relationship and upload data. The Director General of Foreign Trade amends Para 2.90A (vi) and (vii) of the Handbook of Procedure to substitute the earlier implementation date with a later date, extending the deadline for implementation of the Track and Trace system for export consignments of drug formulations. The extension requires maintenance of the parent child relationship in packaging levels and uploading of such data on the Central Portal, and applies to both SSI and non SSI manufactured drugs.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Track and Trace system implementation extended for pharmaceutical exports; exporters must maintain parent child packaging relationship and upload data.
The Director General of Foreign Trade amends Para 2.90A (vi) and (vii) of the Handbook of Procedure to substitute the earlier implementation date with a later date, extending the deadline for implementation of the Track and Trace system for export consignments of drug formulations. The extension requires maintenance of the parent child relationship in packaging levels and uploading of such data on the Central Portal, and applies to both SSI and non SSI manufactured drugs.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.